IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 213 filers reported holding IMMUNOGEN INC in Q3 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,154,116 | -46.1% | 450,795 | -35.9% | 0.00% | -42.9% |
| Q2 2023 | $13,264,043 | +304.1% | 702,917 | -17.8% | 0.01% | +250.0% |
| Q1 2023 | $3,282,190 | +77566.6% | 854,737 | +0.3% | 0.00% | -33.3% |
| Q4 2022 | $4,226 | -99.8% | 852,032 | +45.7% | 0.00% | +50.0% |
| Q3 2022 | $2,795,000 | +63.0% | 584,775 | +53.4% | 0.00% | +100.0% |
| Q2 2022 | $1,715,000 | -5.3% | 381,206 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,811,000 | +3.4% | 380,484 | +61.2% | 0.00% | 0.0% |
| Q4 2021 | $1,751,000 | +264.0% | 235,981 | +178.3% | 0.00% | – |
| Q3 2021 | $481,000 | -14.3% | 84,798 | -0.3% | 0.00% | – |
| Q2 2021 | $561,000 | +65.0% | 85,069 | +102.8% | 0.00% | – |
| Q1 2021 | $340,000 | +30.3% | 41,942 | +3.7% | 0.00% | – |
| Q4 2020 | $261,000 | +75.2% | 40,455 | -2.4% | 0.00% | – |
| Q3 2020 | $149,000 | -19.9% | 41,455 | +2.5% | 0.00% | – |
| Q2 2020 | $186,000 | +31.9% | 40,463 | -2.5% | 0.00% | – |
| Q1 2020 | $141,000 | -31.6% | 41,486 | +2.6% | 0.00% | – |
| Q4 2019 | $206,000 | -47.8% | 40,436 | -75.2% | 0.00% | – |
| Q3 2019 | $395,000 | +11.3% | 163,231 | -0.1% | 0.00% | – |
| Q2 2019 | $355,000 | -65.7% | 163,468 | -40.6% | 0.00% | -100.0% |
| Q1 2019 | $1,034,000 | +56.0% | 275,288 | +99.2% | 0.00% | 0.0% |
| Q4 2018 | $663,000 | -48.9% | 138,217 | +0.9% | 0.00% | -50.0% |
| Q3 2018 | $1,297,000 | -2.6% | 136,949 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $1,331,000 | -7.6% | 136,808 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $1,440,000 | +41.7% | 136,925 | -13.6% | 0.00% | +100.0% |
| Q4 2017 | $1,016,000 | -46.6% | 158,476 | -36.2% | 0.00% | -66.7% |
| Q3 2017 | $1,902,000 | +4.4% | 248,576 | -3.0% | 0.00% | 0.0% |
| Q2 2017 | $1,822,000 | +85.5% | 256,206 | +1.0% | 0.00% | +50.0% |
| Q1 2017 | $982,000 | +93.7% | 253,676 | +2.1% | 0.00% | +100.0% |
| Q4 2016 | $507,000 | -25.4% | 248,576 | -2.0% | 0.00% | 0.0% |
| Q3 2016 | $680,000 | -9.5% | 253,701 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $751,000 | -66.5% | 253,701 | +3.9% | 0.00% | -75.0% |
| Q1 2016 | $2,244,000 | – | 244,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |